{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:51:42Z","timestamp":1791525102657,"version":"4.3.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background\/objectives<\/jats:title>\n                    <jats:p>Heart failure (HF) is one of the leading causes of death and impairs quality of life worldwide. Systemic inflammation has been increasingly recognized as a major contributor to adverse outcomes in patients with heart failure. The Inflammatory Burden Index (IBI), a composite marker integrating C-reactive protein (CRP), neutrophils, and lymphocytes, may offer improved prognostic value over traditional inflammatory markers. This study aimed to evaluate the prognostic significance of IBI in predicting one-year mortality among patients undergoing Cardiac Resynchronization Therapy (CRT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational study included 525 heart failure patients who received CRT between January 2020 and January 2024. Patients were grouped based on 1-year survival status. Continuous variables were compared using Student's t-test or Mann\u2013Whitney U test based on normality assessment, and presented as mean\u2009\u00b1\u2009SD or median [interquartile range, IQR]. To handle right-skewness and ensure linearity in the logit, inflammatory markers were logarithmically transformed [Log(IBI) and Log(CRP)]. Multivariable logistic regression models were constructed using a standardized baseline clinical model. Incremental prognostic value was evaluated using Integrated Discrimination Improvement (IDI), continuous Net Reclassification Improvement (NRI), and DeLong's test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline CRP (median [IQR]: 20.90 [11.95\u201333.00] vs. 6.56 [3.37\u201313.80] mg\/dL,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and IBI (median [IQR]: 81.15 [36.56\u2013230.90] vs. 18.61 [7.76\u201344.46],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) were significantly higher in non-survivors. In multivariable analysis, both Log(IBI) (OR: 1.983; 95% CI: 1.463\u20132.687;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and Log(CRP) (OR: 3.265; 95% CI: 2.278\u20134.678;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) independently predicted 1-year mortality. Incorporating Log(IBI) or Log(CRP) significantly improved model discrimination over baseline clinical risk (AUC increased from 0.684 to 0.778 and 0.795, respectively; DeLong\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), yielding substantial IDI (0.0953 and 0.1118,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and continuous NRI (67.1% and 80.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) gains. Head-to-head comparison showed comparable discriminative performance between Log(IBI) and Log(CRP) models (DeLong\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.307).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both Log(IBI) and Log(CRP) are independent predictors of 1-year mortality in HF patients undergoing CRT, offering comparable incremental prognostic utility over standard clinical risk factors. Incorporating these inflammatory biomarkers into routine risk stratification may refine the identification of high-risk candidates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1934817","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:30:37Z","timestamp":1791523837000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of the inflammatory burden index in predicting 1-year mortality in patients undergoing cardiac resynchronization therapy for heart failure"],"prefix":"10.3389","volume":"13","author":[{"given":"Rustem","family":"Yilmaz","sequence":"first","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Samsun University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Toprak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Harran University","place":["\u015eanl\u0131urfa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Karagoz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Samsun University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Can","family":"Yontar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Samsun University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Yolcu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Istinye University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Turan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Samsun University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk","family":"Boyaci","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Samsun University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okan Oguzhan","family":"Ovaz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Samsun University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre Kasim","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Samsun University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enes Furkan","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Samsun University","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersoy","family":"\u00d6z","sequence":"additional","affiliation":[{"name":"Department of Statistics, Yildiz Technical University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-017-0660-3","article-title":"Role of inflammation in heart failure","volume":"19","author":"Shirazi","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation\u2014cause or consequence of heart failure or both?","volume":"14","author":"Van Linthout","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: jACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.11909\/j.issn.1671-5411.2019.07.005","article-title":"The relevance of serum albumin among elderly patients with acute decompensated heart failure","volume":"16","author":"Mene-Afejuku","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/00015385.2018.1521557","article-title":"Serum albumin level and long-term outcome in acute heart failure","volume":"74","author":"Ancion","year":"2019","journal-title":"Acta Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00380-019-01435-9","article-title":"Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure","volume":"34","author":"Matsumoto","year":"2019","journal-title":"Heart Vessels"},{"key":"B7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijcard.2015.04.043","article-title":"Lymphocyte count and prognosis in patients with heart failure","volume":"188","author":"Mar\u00e7ula","year":"2015","journal-title":"Int J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","article-title":"C-reactive protein in heart failure: prognostic value and the effect of valsartan","volume":"112","author":"Anand","year":"2005","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/cvr\/cvz198","article-title":"High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death","volume":"116","author":"Pellicori","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocar- dial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e33438","DOI":"10.1371\/journal.pone.0033438","article-title":"Enhanced in- terleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure","volume":"7","author":"Van Tassell","year":"2012","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00011-013-0625-0","article-title":"Interleukin-1beta induces a reversible cardiomyopathy in the mouse","volume":"62","author":"Van Tassell","year":"2013","journal-title":"Inflamm Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ahj.2005.06.046","article-title":"Inflammation and long-term mortality in acute congestive heart fail- ure","volume":"151","author":"Mueller","year":"2006","journal-title":"Am Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0735-1097(02)01932-0","article-title":"Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisiteSTimulation in cardiomyopathy (MUSTIC) study","volume":"40","author":"Linde","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/CIRCULATIONAHA.110.014324","article-title":"Predictors of response to cardiac resynchronization therapy in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT)","volume":"124","author":"Goldenberg","year":"2011","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Multicenter InSync randomized clinical evaluation. Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the framingham heart study","volume":"107","author":"Vasan","year":"2003","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic heart failure and inflammation: what do we really know?","volume":"119","author":"Dick","year":"2016","journal-title":"Circ Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.12659\/MSM.883915","article-title":"Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy","volume":"19","author":"Agacdiken","year":"2013","journal-title":"Med Sci Monit"},{"key":"B21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/europace\/euv100","article-title":"The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy","volume":"18","author":"Boros","year":"2016","journal-title":"Europace"},{"key":"B22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.clinbiochem.2014.01.032","article-title":"Cardiac biomarkers in heart failure","volume":"47","author":"Liquori","year":"2014","journal-title":"Clin. Biochem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.36516\/jocass.1139629","article-title":"The role of the systemic immune-inflammation index in predicting response to cardiac resynchronization therapy","volume":"5","author":"\u00c7elik","year":"2022","journal-title":"J Cukurova Anesth Surg Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.clnu.2022.04.019","article-title":"Inflammatory burden as a prognostic biomarker for cancer","volume":"41","author":"Xie","year":"2022","journal-title":"Clin Nutr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/0022146513485244","article-title":"Social isolation and adult mortality: the role of chronic inflammation and sex differences","volume":"54","author":"Yang","year":"2013","journal-title":"J Health Soc Behav"},{"key":"B26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.numecd.2023.10.006","article-title":"Association between inflammatory burden index and all-cause mortality in the general population aged over 45 years: data from NHANES 2005\u20132017","volume":"34","author":"He","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Fail"},{"key":"B28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.hrthm.2007.09.023","article-title":"Cardiac resynchronization therapy: \u201cnonresponders\u201d and \u201chyperresponders\u201d","volume":"5","author":"Castellant","year":"2008","journal-title":"Heart Rhythm"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.jacc.2012.01.065","article-title":"Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study","volume":"59","author":"Hsu","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/clc.22658","article-title":"Predictors and long-term outcome of super-responders to cardiac resynchronization therapy","volume":"40","author":"Ghani","year":"2017","journal-title":"Clin Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.11909\/j.issn.1671-5411.2017.12.003","article-title":"Predictors of super-response to cardiac resynchronization therapy: the significance of heart failure medication, pre-implant left ventricular geometry and high percentage of biventricular pacing","volume":"14","author":"Jin","year":"2017","journal-title":"J Geriatr Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ihj.2019.09.007","article-title":"Incidence and predictors of super-response to cardiac resynchronization therapy","volume":"71","author":"Rohit","year":"2019","journal-title":"Indian Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.repc.2016.10.010","article-title":"Predictors of response to cardiac resynchronization therapy: a prospective cohort study","volume":"36","author":"Abreu","year":"2017","journal-title":"Rev Port Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.11909\/j.issn.1671-5411.2019.07.009","article-title":"Predictors of non-response to cardiac resynchronization therapy implantation in patients with class I indications: the markedly dilated left ventricular end-diastolic dimension and the presence of fragmented QRS","volume":"16","author":"Hu","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/europace\/eus045","article-title":"Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis","volume":"14","author":"Dong","year":"2012","journal-title":"Europace"},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ahj.2013.03.021","article-title":"Effect of atrioventricular and ventriculoventricular delay optimization on clinical and echocardiographic outcomes of patients treated with cardiac resynchronization therapy: a meta-analysis","volume":"166","author":"Auger","year":"2013","journal-title":"Am Heart J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ijcard.2016.09.078","article-title":"Predictors of response to cardiac resynchronization therapy: a systematic review","volume":"225","author":"Rickard","year":"2016","journal-title":"Int J Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/jcdd11070206","article-title":"Systematic review on the role of IL-6 and IL-1\u03b2 in cardiovascular diseases","volume":"11","author":"Katkenov","year":"2024","journal-title":"J Cardiovasc Dev Dis"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1934817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:30:41Z","timestamp":1791523841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1934817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":38,"alternative-id":["10.3389\/fcvm.2026.1934817"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1934817","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"1934817"}}